
BioNano Genomics BNGO
$ 1.21
0.0%
Annual report 2025
added 03-23-2026
BioNano Genomics DPO Ratio 2011-2026 | BNGO
Annual DPO Ratio BioNano Genomics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 149 | 104 | 158 | 195 | 177 | 187 | 146 | 56.6 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 195 | 56.6 | 146 |
Quarterly DPO Ratio BioNano Genomics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 140 | 179 | 175 | - | 54.8 | 163 | 155 | - | 189 | 199 | 242 | - | 79.3 | 57.8 | 154 | - | 151 | 112 | 110 | - | 183 | 443 | 300 | 146 | 104 | 158 | 161 | 41.3 | 40.2 | 68 | 198 | 140 | 62.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 443 | 40.2 | 150 |
DPO Ratio of other stocks in the Diagnostics research industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Trinity Biotech plc
TRIB
|
163 | $ 0.65 | -1.84 % | $ 61.9 M | ||
|
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M | ||
|
Agilent Technologies
A
|
50.1 | $ 115.55 | 1.0 % | $ 35.1 B | ||
|
Accelerate Diagnostics
AXDX
|
125 | - | -61.36 % | $ 2.46 M | ||
|
Aspira Women's Health
AWH
|
189 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
52.5 | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
4.24 K | $ 1.67 | -2.34 % | $ 2.22 M | ||
|
Castle Biosciences
CSTL
|
52 | $ 24.46 | 3.25 % | $ 679 M | ||
|
CareDx, Inc
CDNA
|
44.2 | $ 21.23 | 5.83 % | $ 1.13 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
45.8 | - | - | $ 562 M | ||
|
DermTech
DMTK
|
47.4 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
23.6 | $ 84.33 | 1.82 % | $ 5.69 B | ||
|
Enzo Biochem
ENZ
|
52.3 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
49.2 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
34.9 | $ 16.31 | 1.75 % | $ 493 M | ||
|
Medpace Holdings
MEDP
|
13.3 | $ 410.54 | 4.35 % | $ 11.8 B | ||
|
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
780 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
24.5 | $ 169.8 | 1.23 % | $ 8.42 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | ||
|
Guardant Health
GH
|
48.6 | $ 88.91 | 1.18 % | $ 11.1 B | ||
|
HTG Molecular Diagnostics
HTGM
|
112 | - | -20.0 % | $ 1.06 M | ||
|
Heska Corporation
HSKA
|
39.7 | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
33 | $ 1.98 | -2.37 % | $ 8.76 M | ||
|
Illumina
ILMN
|
56.3 | $ 127.88 | 1.95 % | $ 20.3 B | ||
|
National Research Corporation
NRC
|
10.1 | $ 17.23 | -0.12 % | $ 386 M | ||
|
Personalis
PSNL
|
67.3 | $ 6.1 | 3.39 % | $ 361 M | ||
|
QIAGEN N.V.
QGEN
|
50 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
32.4 | $ 2.14 | -0.47 % | $ 4.92 M | ||
|
ICON Public Limited Company
ICLR
|
6.52 | $ 102.17 | -3.92 % | $ 8.43 B | ||
|
Laboratory Corporation of America Holdings
LH
|
31.5 | $ 263.8 | -0.43 % | $ 21.9 B | ||
|
Motus GI Holdings
MOTS
|
1.72 | - | -34.28 % | $ 263 K | ||
|
Thermo Fisher Scientific
TMO
|
49.3 | $ 469.71 | 0.64 % | $ 177 B | ||
|
NeoGenomics
NEO
|
19.7 | $ 8.29 | 4.8 % | $ 1.06 B | ||
|
Neogen Corporation
NEOG
|
62.7 | $ 9.54 | 2.03 % | $ 2.07 B | ||
|
Twist Bioscience Corporation
TWST
|
12.5 | $ 60.94 | 3.55 % | $ 3.64 B | ||
|
Myriad Genetics
MYGN
|
45.9 | $ 4.78 | -0.21 % | $ 443 M | ||
|
Natera
NTRA
|
17.9 | $ 203.75 | 1.3 % | $ 20.1 B | ||
|
Quest Diagnostics Incorporated
DGX
|
14.7 | $ 196.27 | -1.66 % | $ 21.8 B | ||
|
Invitae Corporation
NVTA
|
69 | - | - | $ 21.2 M | ||
|
Organovo Holdings
ONVO
|
82.9 K | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
95 | - | -16.95 % | $ 1.54 M | ||
|
Waters Corporation
WAT
|
102 | $ 309.87 | -0.43 % | $ 18.5 B |